These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 29091568

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vascular Effects of ACE (Angiotensin-Converting Enzyme) Inhibitors and Statins in Adolescents With Type 1 Diabetes.
    Chiesa ST, Marcovecchio ML, Benitez-Aguirre P, Cameron FJ, Craig ME, Couper JJ, Davis EA, Dalton RN, Daneman D, Donaghue KC, Jones TW, Mahmud FH, Marshall SM, Neil HAW, Dunger DB, Deanfield JE, Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT) Study Group.
    Hypertension; 2020 Dec; 76(6):1734-1743. PubMed ID: 33100044
    [Abstract] [Full Text] [Related]

  • 3. Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT).
    Adolescent type 1 Diabetes cardio-renal Intervention Trial Research GroupDepartment of Paediatrics, University of Cambridge, Level 8 Box 116, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK. dbd25@cam.ac.uk.
    BMC Pediatr; 2009 Dec 17; 9():79. PubMed ID: 20017932
    [Abstract] [Full Text] [Related]

  • 4. Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments.
    Marcovecchio ML, Woodside J, Jones T, Daneman D, Neil A, Prevost T, Dalton RN, Deanfield J, Dunger DB, AdDIT Investigators.
    Diabetes Care; 2014 Dec 17; 37(3):805-13. PubMed ID: 24198300
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Jin SM, Han KA, Yu JM, Sohn TS, Choi SH, Chung CH, Park IeB, Rhee EJ, Baik SH, Park TS, Lee IK, Ko SH, Hwang YC, Cha BS, Lee HW, Nam MS, Lee MK.
    Arterioscler Thromb Vasc Biol; 2016 Oct 17; 36(10):2108-14. PubMed ID: 27493100
    [Abstract] [Full Text] [Related]

  • 9. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.
    Health Technol Assess; 2005 Aug 17; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [Abstract] [Full Text] [Related]

  • 10. Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.
    Heerspink HJ, Persson F, Brenner BM, Chaturvedi N, Brunel P, McMurray JJ, Desai AS, Solomon SD, Pfeffer MA, Parving HH, de Zeeuw D.
    Lancet Diabetes Endocrinol; 2016 Apr 17; 4(4):309-17. PubMed ID: 26774608
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
    Tobe SW, Clase CM, Gao P, McQueen M, Grosshennig A, Wang X, Teo KK, Yusuf S, Mann JF, ONTARGET and TRANSCEND Investigators.
    Circulation; 2011 Mar 15; 123(10):1098-107. PubMed ID: 21357827
    [Abstract] [Full Text] [Related]

  • 12. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data.
    ACE Inhibitors in Diabetic Nephropathy Trialist Group.
    Ann Intern Med; 2001 Mar 06; 134(5):370-9. PubMed ID: 11242497
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH, Nagalla S, Ballas SK.
    Cochrane Database Syst Rev; 2015 Jun 04; 2015(6):CD009191. PubMed ID: 26041152
    [Abstract] [Full Text] [Related]

  • 14. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
    de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM.
    Arch Intern Med; 2011 Mar 14; 171(5):412-20. PubMed ID: 21403038
    [Abstract] [Full Text] [Related]

  • 15. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.
    Kidney Int; 2000 Feb 14; 57(2):590-600. PubMed ID: 10652036
    [Abstract] [Full Text] [Related]

  • 16. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK, Chaturvedi N, Fuller J.
    Ugeskr Laeger; 1999 Feb 15; 161(7):949-52. PubMed ID: 10051804
    [Abstract] [Full Text] [Related]

  • 17. Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study.
    Böger CA, Haak T, Götz AK, Christ J, Ruff E, Hoffmann U, Riegger GA, Krämer BK.
    Int J Clin Pharmacol Ther; 2006 Aug 15; 44(8):364-74. PubMed ID: 16961167
    [Abstract] [Full Text] [Related]

  • 18. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R.
    Ann Intern Med; 1998 Jun 15; 128(12 Pt 1):982-8. PubMed ID: 9625684
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH, Nagalla S, Ballas SK.
    Cochrane Database Syst Rev; 2013 Mar 28; (3):CD009191. PubMed ID: 23543572
    [Abstract] [Full Text] [Related]

  • 20. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM, McGill JB, Gans DJ.
    Am J Med; 1995 Nov 28; 99(5):497-504. PubMed ID: 7485207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.